A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors
Authors
Keywords
Japanese, LY2940680, Phase I, Solid tumors, Sonic hedgehog pathway, Taladegib
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-02-17
DOI
10.1007/s10637-017-0544-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1b/2 trial of taladegib (LY2940680), a Hh/Smo inhibitor, in combination with carboplatin and etoposide followed by taladegib maintenance in extensive-stage small-cell lung cancer
- (2016) E. Schaefer et al. EUROPEAN JOURNAL OF CANCER
- Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
- (2016) Tadas Rimkus et al. Cancers
- Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
- (2015) M Zuo et al. BRITISH JOURNAL OF CANCER
- Abstract B32: LY2940680, a hedgehog (Hh) pathway inhibitor, demonstrates anti-tumor activity in patients with advanced basal cell carcinoma (BCC)
- (2015) Johanna Bendell et al. MOLECULAR CANCER THERAPEUTICS
- Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
- (2014) Dorothee Riedlinger et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer
- (2014) Tobias Kiesslich et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Advanced Treatment for Basal Cell Carcinomas
- (2014) S. X. Atwood et al. Cold Spring Harbor Perspectives in Medicine
- Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib
- (2013) Anne Lynn S. Chang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Abstract 2819: Identification and characterization of a novel smoothened antagonist for the treatment of cancer with deregulated hedgehog signaling
- (2012) Mark H. Bender et al. CANCER RESEARCH
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy
- (2009) P. H. O'Donnell et al. CLINICAL CANCER RESEARCH
- Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer Agents
- (2009) Neeraj Mahindroo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology of biliary tract cancers: an update
- (2008) G. Randi et al. ANNALS OF ONCOLOGY
- Hedgehog Signaling in Development and Cancer
- (2008) Jin Jiang et al. DEVELOPMENTAL CELL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search